Norvasc amlodipine besylate

Norvasc is a widely prescribed cardiovascular medication containing amlodipine besylate, used to treat hypertension (high blood pressure) and angina (chest pain). Originally developed and patented by Pfizer, it represents one of the most significant advancements in calcium channel blocker therapy. Today, it remains a cornerstone of Pfizer's established medicine portfolio.

The manufacturing of Norvasc occurs across a global network of specialized pharmaceutical facilities to ensure supply chain resilience. Key production hubs include Germany, the United States, and Ireland. The brand is managed by Viatris in certain markets following the 2020 merger of Mylan and Pfizer's Upjohn division, though Pfizer remains the primary global entity associated with its historical development and ongoing presence.